$CDLX

Cardlytics: Q2 Earnings Snapshot

Cardlytics (CDLX) reported a Q2 loss of $14.9 million, or $2.58 per share. Adjusted for discontinued operations, the loss was $1.50 per share. Revenue was $36.9 million. For the quarter ending September, the company expects revenue of $34 million to $39 million.

Original reporting
Published Aug 5, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 11:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CDLX
Bearish
medium confidence
Mentioned
$CDLX
Relevance
8/10
alphai data visualization · based on local3news.com
Decision brief

The 30-second read

$CDLXBearishMed
01

Why it matters

Traders can update models and expectations using the disclosed Q2 results and the stated Q3 revenue range for near-term sentiment and positioning.

02

Market read

Company-specific earnings and guidance provide a fresh basis for adjusting near-term expectations for CDLX.

03

What to watch

The article does not include margin, cash flow, or segment detail, so traders may be over-weighting the headline loss without assessing underlying operating trends.

Relevance 8/10Novelty 7/10Timing: reported Q2 results and Q3 revenue guidance on Wednesday

Background

AP earnings snapshot for Cardlytics, including quarterly loss, revenue, and next-quarter revenue guidance.

Company-level read

Ticker impact

$CDLXBearishMedium confidence
Context

Cardlytics reported Q2 loss of $2.58 per share and revenue of $36.9 million, plus Q3 revenue guidance of $34M to $39M.

Expected impact

Likely downside bias on any pre-market reaction if investors focus on losses and the breadth of the revenue outlook.

Evidence & confidence

The article discloses a quarterly loss and provides explicit next-quarter revenue guidance, which typically moves small-cap ad-tech/marketing analytics names on expectations.

Market effects

Adds datapoint on demand and monetization trajectory for customer engagement/marketing analytics providers.

Limited, as the disclosure is company-specific.

Low, no cross-border or macro linkage described.

Counterpoint

Investors may focus less on GAAP loss and more on revenue trajectory versus prior expectations, using the guidance range as a signal of stabilization.

Key entities

  • Cardlytics, Inc.

    Reported Q2 loss and revenue, and provided Q3 revenue guidance range.

Related articles

$CDLXMed

Cardlytics, Inc. (CDLX): Results of Operations and Financial Condition

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cdlx_form8-kx2026q2xex991.htm EX-99.1 Document Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Con

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.